Transjugular Intrahepatic Portosystemic Shunts for Acute and Chronic Portal Vein Thrombosis in Preparation for Liver Transplant

Abstract

The presence of portal vein thrombosis (PVT) in the pre-liver transplant patient can significantly impact waitlist, peri- and posttransplant outcomes, morbidity, and mortality. This article describes the pathophysiology of PVT and treatment options in patients with cirrhosis. It defines indications and rationale for placing transjugular intrahepatic portosystemic shunts, emphasizing technical details and risks in patients with nonneoplastic PVT awaiting liver transplantation.

Keywords

portal vein thrombosis - transjugular intrahepatic portosystemic shunt - liver transplant

Publikationsverlauf

Eingereicht: 14. April 2024

Angenommen: 09. September 2024

Artikel online veröffentlicht:
25. November 2024

• References

• 1 Ramalingam V, Yang LM, McCarthy CJ, Ahmed M. Interventional approach to portal vein thrombosis and liver transplantation: state of the art. Life (Basel) 2023; 13 (06) 1262
• 2 Ponziani ER, Zacco MA, Senzolo M. et al Portal vein thrombosis and liver transplantation. Transplant Rev 2014; 8: 92-101
• 3 Novelli PM, Tublin JM, Orons PD. Correcting coagulopathy for image-guided procedures. Semin Intervent Radiol 2022; 39 (04) 428-434
• 4 Francoz C, Belghiti J, Vilgrain V. et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54 (05) 691-697
• 5 Cho JY, Suh KS, Shin WY, Lee HW, Yi NJ, Lee KU. Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg 2008; 32 (08) 1731-1737
• 6 Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010; 16 (08) 999-1005
• 7 DeLeeuw P, Agbim U. Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients-pathogenesis, risk factors, and implications on management. Transl Gastroenterol Hepatol 2022; 7: 27
• 8 Swan D, Lisman T, Tripodi A, Thachil J. The prothrombotic tendency of metabolic-associated fatty liver disease. J Thromb Haemost 2023; 21 (11) 3045-3055
• 9 Yerdel MA, Gunson B, Mirza D. et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69 (09) 1873-1881
• 10 Bozzato AM, Bruno O, Payance A. et al. Portal vein thrombosis: Baveno VII consensus recommendations for diagnosis and management. Radiographics 2023; 43 (11) e230128
• 11 Werner KT, Sando S, Carey EJ. et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci 2013; 58 (06) 1776-1780
• 12 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 2019; 156 (06) 1582-1599.e1
• 13 Basili S, Pastori D, Raparelli V, Violi F. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician. Therap Adv Gastroenterol 2018; 11: 1756284818793561
• 14 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021; 22 (04) 176-186 [ Erratum in: J Dig Dis. 2021 May;22(5):295. PMID: 33470535; PMCID: PMC8252415]
• 15 Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 2015; 26 (01) 23-29
• 16 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 2017; 153 (02) 480-487.e1
• 17 Guerrero A, Campo LD, Piscaglia F. et al; Baveno Cooperation: An EASL Consortium. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis. J Hepatol 2023; 79 (01) 69-78
• 18 Mui B, Grinspan L, Crismale J. Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study. Am J Gastroenterol 2024; 119 (04) 774-777
• 19 European Association for the Study of the Liver. Electronic address: [e-mail]. Vascular diseases of the liver. J Hepatol 2016; 64 (01) 179-202
• 20 Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG clinical guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020; 115 (01) 18-40
• 21 de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 2022; 76 (04) 959-974
• 22 Agbim U, Satapathy SK. PRO: portal vein thrombosis impacts liver transplantation outcomes. Clin Liver Dis (Hoboken) 2020; 16 (04) 127-131
• 23 Rizzari MD, Safwan M, Sobolic M. et al. The impact of portal vein thrombosis on liver transplant outcomes: Does grade or flow rate matter?. Transplantation 2021; 105 (02) 363-371
• 24 Radosevich PM, Ring EJ, LaBerge JM. et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993; 186 (02) 523-527
• 25 Lv Y, Bai W, Li K. et al. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study. Am J Gastroenterol 2021; 116 (07) 1447-1464 [Erratum in Am. J. Gastroenterol. 2022, 117, 200]
• 26 Lee EW, Eghtesad B, Garcia-Tsao G. et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology 2024; 79 (01) 224-250 I
• 27 Entezari P, Riaz A, Thornburg B, Salem R. Percutaneous ultrasound-guided superior and inferior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt: a case series. Cardiovasc Intervent Radiol 2021; 44 (03) 496-499
• 28 Thornburg B, Desai K, Hickey R. et al. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort. J Vasc Interv Radiol 2017; 28 (12) 1714-1721.e2
• 29 Talwar A, Varghese J, Knight GM. et al. Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: outcomes following liver transplantation. Hepatol Commun 2022; 6 (07) 1803-1812